MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with L

Lomitapide

Lomitapide 5mg capsules

Use with caution

Stability notes for Lomitapide 5mg capsules

Store in an airtight container and protect from moisture.

Provenance

This compatibility recommendation is derived from Lojuxta 5mg capsules (Amryt Pharma (UK) Ltd).

Supplier

Lojuxta 5mg capsules (Chiesi Ltd)

Lomitapide 10mg capsules

Use with caution

Stability notes for Lomitapide 10mg capsules

Store in an airtight container and protect from moisture.

Provenance

This compatibility recommendation is derived from Lojuxta 10mg capsules (Amryt Pharma (UK) Ltd).

Supplier

Lojuxta 10mg capsules (Chiesi Ltd)

Lomitapide 20mg capsules

Use with caution

Stability notes for Lomitapide 20mg capsules

Store in an airtight container and protect from moisture.

Provenance

This compatibility recommendation is derived from Lojuxta 20mg capsules (Amryt Pharma (UK) Ltd).

Supplier

Lojuxta 20mg capsules (Chiesi Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.